Penn team adapts CAR-T tech, reengi­neer­ing mouse cells to treat car­diac fi­bro­sis

Af­ter es­tab­lish­ing it­self as one of the pi­o­neer re­search cen­ters in the world for CAR-T can­cer ther­a­pies, cre­at­ing new at­tack ve­hi­cles to erad­i­cate can­cer cells, a team at Penn Med­i­cine has be­gun the tricky tran­si­tion of us­ing the ba­sic tech­nol­o­gy for heart re­pair work.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER